PubMed:30744880
Annnotations
maxiaofeng52_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 885-894 | CI | denotes | vitamin D |
| T2 | 33-42 | CI | denotes | vitamin D |
| T3 | 430-439 | CI | denotes | vitamin D |
| T4 | 609-618 | CI | denotes | vitamin D |
| T5 | 1955-1964 | CI | denotes | vitamin D |
| T6 | 620-665 | CI | denotes | omega-3 long chain polyunsaturated fatty acid |
| T7 | 47-93 | CI | denotes | omega-3 long chain polyunsaturated fatty acids |
| T8 | 667-681 | CI | denotes | omega-3 LCPUFA |
| T9 | 915-929 | CI | denotes | omega-3 LCPUFA |
| T10 | 1969-1983 | CI | denotes | omega-3 LCPUFA |
| T11 | 973-983 | CI | denotes | vitamin D |
| T12 | 909-912 | CI | denotes | VID |
| T13 | 1444-1447 | CI | denotes | VID |
| T14 | 1564-1567 | CI | denotes | VID |
| T15 | 1716-1719 | CI | denotes | VID |
| T16 | 942-945 | CI | denotes | DHA |
| T17 | 705-708 | CI | denotes | DHA |
| T18 | 996-999 | CI | denotes | DHA |
| T19 | 947-949 | CI | denotes | OM |
| T20 | 1413-1415 | CI | denotes | OM |
| T21 | 1839-1841 | CI | denotes | OM |
| T22 | 1001-1006 | CI | denotes | VIDOM |
| T23 | 1736-1741 | CI | denotes | VIDOM |
| T24 | 1867-1872 | CI | denotes | VIDOM |
| T25 | 535-541 | CI | denotes | VIDOMA |
| T26 | 543-552 | CI | denotes | Vitamin D |
| T27 | 2036-2045 | CI | denotes | Vitamin D |
| T28 | 557-564 | CI | denotes | Omega-3 |
| T29 | 444-463 | CI | denotes | omega-3 fatty acids |
| T30 | 250-274 | DP | denotes | Autism Spectrum Disorder |
| T31 | 276-279 | DP | denotes | ASD |
| T32 | 568-571 | DP | denotes | ASD |
| T33 | 781-784 | DP | denotes | ASD |
| T34 | 2031-2034 | DP | denotes | ASD |
| T35 | 165-189 | DP | denotes | autism spectrum disorder |
| T36 | 683-703 | CI | denotes | docosahexaenoic acid |
| T37 | 1543-1550 | CI | denotes | placebo |
| T38 | 857-864 | CI | denotes | placebo |
| T39 | 1512-1519 | CI | denotes | placebo |
wangzhuo19_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 33-42 | CI | denotes | vitamin D |
| T10 | 915-929 | CI | denotes | omega-3 LCPUFA |
| T11 | 1969-1983 | CI | denotes | omega-3 LCPUFA |
| T12 | 683-703 | CI | denotes | docosahexaenoic acid |
| T13 | 705-708 | CI | denotes | DHA |
| T14 | 942-945 | CI | denotes | DHA |
| T15 | 996-999 | CI | denotes | DHA |
| T16 | 543-552 | CI | denotes | Vitamin D |
| T17 | 2036-2045 | CI | denotes | Vitamin D |
| T18 | 557-564 | CI | denotes | Omega-3 |
| T19 | 857-864 | CI | denotes | placebo |
| T2 | 430-439 | CI | denotes | vitamin D |
| T20 | 1512-1519 | CI | denotes | placebo |
| T21 | 1543-1550 | CI | denotes | placebo |
| T23 | 909-912 | CI | denotes | VID |
| T24 | 1444-1447 | CI | denotes | VID |
| T25 | 1564-1567 | CI | denotes | VID |
| T26 | 1716-1719 | CI | denotes | VID |
| T27 | 947-949 | CI | denotes | OM |
| T28 | 1413-1415 | CI | denotes | OM |
| T29 | 1839-1841 | CI | denotes | OM |
| T3 | 609-618 | CI | denotes | vitamin D |
| T30 | 1001-1006 | CI | denotes | VIDOM |
| T31 | 1736-1741 | CI | denotes | VIDOM |
| T32 | 1867-1872 | CI | denotes | VIDOM |
| T33 | 973-983 | CI | denotes | vitamin D |
| T34 | 165-189 | DP | denotes | autism spectrum disorder |
| T35 | 250-274 | DP | denotes | Autism Spectrum Disorder |
| T36 | 276-279 | DP | denotes | ASD |
| T37 | 568-571 | DP | denotes | ASD |
| T38 | 781-784 | DP | denotes | ASD |
| T39 | 2031-2034 | DP | denotes | ASD |
| T4 | 885-894 | CI | denotes | vitamin D |
| T5 | 1955-1964 | CI | denotes | vitamin D |
| T6 | 47-93 | CI | denotes | omega-3 long chain polyunsaturated fatty acids |
| T7 | 620-665 | CI | denotes | omega-3 long chain polyunsaturated fatty acid |
| T8 | 444-463 | CI | denotes | omega-3 fatty acids |
| T9 | 667-681 | CI | denotes | omega-3 LCPUFA |
| T40 | 535-541 | CI | denotes | VIDOMA |